Winton Group’s Celldex Therapeutics CLDX Stock Holding History

Winton Group’s Portfolio CLDX Stock Details CLDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$224K	Buy
2020 Q4	–	Sell
2020 Q3	$359K	Buy
2020 Q2	$252K	Buy
2020 Q1	$20K	Sell
2019 Q4	$71K	Sell
2019 Q3	$72K	Buy